Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 57 Million CNY | 17.41% |
| 2022 | 48.54 Million CNY | -30.27% |
| 2021 | 69.62 Million CNY | 119.7% |
| 2020 | -353.47 Million CNY | -520.93% |
| 2019 | 83.97 Million CNY | -20.85% |
| 2018 | 106.09 Million CNY | -18.14% |
| 2017 | 129.6 Million CNY | -28.81% |
| 2016 | 182.05 Million CNY | -16.0% |
| 2015 | 216.73 Million CNY | 20.29% |
| 2014 | 180.17 Million CNY | 61.53% |
| 2013 | 111.54 Million CNY | 714.06% |
| 2012 | 13.7 Million CNY | -21.95% |
| 2011 | 17.55 Million CNY | 209.38% |
| 2010 | 5.67 Million CNY | 123.92% |
| 2009 | -23.71 Million CNY | -641.0% |
| 2008 | 4.38 Million CNY | -68.21% |
| 2007 | 13.79 Million CNY | 377.0% |
| 2006 | 2.89 Million CNY | -62.84% |
| 2005 | 7.78 Million CNY | -48.46% |
| 2004 | 15.09 Million CNY | 153.84% |
| 2003 | -28.03 Million CNY | 72.76% |
| 2002 | -102.91 Million CNY | -135.64% |
| 2001 | -43.67 Million CNY | -751.4% |
| 2000 | 6.7 Million CNY | 4.06% |
| 1999 | 6.44 Million CNY | 65.69% |
| 1998 | 3.88 Million CNY | -59.65% |
| 1997 | 9.63 Million CNY | -30.64% |
| 1996 | 13.89 Million CNY | -36.78% |
| 1995 | 21.97 Million CNY | -25.58% |
| 1994 | 29.52 Million CNY | -16.3% |
| 1993 | 35.28 Million CNY | 67.64% |
| 1992 | 21.04 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 13.89 Million CNY | -41.98% |
| 2024 Q3 | 21.51 Million CNY | 54.88% |
| 2024 Q1 | 23.94 Million CNY | 367.6% |
| 2023 Q3 | 31.21 Million CNY | 185.18% |
| 2023 Q1 | 23.79 Million CNY | 366.61% |
| 2023 Q2 | 10.94 Million CNY | -54.0% |
| 2023 FY | 57 Million CNY | 17.41% |
| 2023 Q4 | -8.94 Million CNY | -128.67% |
| 2022 Q4 | -8.92 Million CNY | -138.02% |
| 2022 Q2 | 8.5 Million CNY | -63.74% |
| 2022 Q3 | 23.47 Million CNY | 175.89% |
| 2022 FY | 48.54 Million CNY | -30.27% |
| 2022 Q1 | 23.46 Million CNY | 41.37% |
| 2021 Q2 | 22.57 Million CNY | 3.55% |
| 2021 Q1 | 21.79 Million CNY | 111.22% |
| 2021 FY | 69.62 Million CNY | 119.7% |
| 2021 Q3 | 8.65 Million CNY | -61.67% |
| 2021 Q4 | 16.59 Million CNY | 91.82% |
| 2020 Q1 | 8.67 Million CNY | 480.14% |
| 2020 Q2 | 19.85 Million CNY | 128.79% |
| 2020 Q3 | -175.49 Million CNY | -983.98% |
| 2020 Q4 | -194.23 Million CNY | -10.68% |
| 2020 FY | -353.47 Million CNY | -520.93% |
| 2019 FY | 83.97 Million CNY | -20.85% |
| 2019 Q4 | 1.49 Million CNY | -94.09% |
| 2019 Q3 | 25.32 Million CNY | -24.2% |
| 2019 Q2 | 33.41 Million CNY | 40.8% |
| 2019 Q1 | 23.73 Million CNY | -42.64% |
| 2018 Q3 | 6.14 Million CNY | -78.35% |
| 2018 Q4 | 41.37 Million CNY | 572.88% |
| 2018 FY | 106.09 Million CNY | -18.14% |
| 2018 Q1 | 30.17 Million CNY | -38.46% |
| 2018 Q2 | 28.39 Million CNY | -5.88% |
| 2017 Q2 | 29.78 Million CNY | 39.13% |
| 2017 Q3 | 29.38 Million CNY | -1.36% |
| 2017 Q4 | 49.03 Million CNY | 66.88% |
| 2017 FY | 129.6 Million CNY | -28.81% |
| 2017 Q1 | 21.4 Million CNY | -74.52% |
| 2016 Q3 | 28.84 Million CNY | -8.25% |
| 2016 Q2 | 31.43 Million CNY | -16.72% |
| 2016 FY | 182.05 Million CNY | -16.0% |
| 2016 Q4 | 84.02 Million CNY | 191.3% |
| 2016 Q1 | 37.74 Million CNY | -45.88% |
| 2015 Q2 | 47.19 Million CNY | 0.25% |
| 2015 Q1 | 47.07 Million CNY | 3.98% |
| 2015 FY | 216.73 Million CNY | 20.29% |
| 2015 Q4 | 69.75 Million CNY | 32.35% |
| 2015 Q3 | 52.7 Million CNY | 11.68% |
| 2014 Q4 | 45.27 Million CNY | -3.95% |
| 2014 FY | 180.17 Million CNY | 61.53% |
| 2014 Q2 | 59.55 Million CNY | 111.21% |
| 2014 Q1 | 28.19 Million CNY | -46.94% |
| 2014 Q3 | 47.13 Million CNY | -20.85% |
| 2013 Q3 | 19.89 Million CNY | -40.99% |
| 2013 FY | 111.54 Million CNY | 714.06% |
| 2013 Q4 | 53.14 Million CNY | 167.16% |
| 2013 Q1 | 4.78 Million CNY | -0.09% |
| 2013 Q2 | 33.71 Million CNY | 604.18% |
| 2012 Q2 | 8.77 Million CNY | 139.27% |
| 2012 Q3 | -3.53 Million CNY | -140.27% |
| 2012 Q4 | 4.79 Million CNY | 235.59% |
| 2012 FY | 13.7 Million CNY | -21.95% |
| 2012 Q1 | 3.66 Million CNY | 17.8% |
| 2011 FY | 17.55 Million CNY | 209.38% |
| 2011 Q4 | 3.11 Million CNY | 117.61% |
| 2011 Q3 | 1.43 Million CNY | -80.06% |
| 2011 Q2 | 7.17 Million CNY | 22.96% |
| 2011 Q1 | 5.83 Million CNY | 158.03% |
| 2010 Q3 | 3.43 Million CNY | -60.86% |
| 2010 Q1 | 3.51 Million CNY | 110.37% |
| 2010 Q2 | 8.77 Million CNY | 149.39% |
| 2010 FY | 5.67 Million CNY | 123.92% |
| 2010 Q4 | -10.05 Million CNY | -392.78% |
| 2009 Q2 | 6.55 Million CNY | 5264.42% |
| 2009 FY | -23.71 Million CNY | -641.0% |
| 2009 Q4 | -33.94 Million CNY | -994.29% |
| 2009 Q3 | 3.79 Million CNY | -42.12% |
| 2009 Q1 | -126.99 Thousand CNY | 98.56% |
| 2008 Q3 | 6.27 Million CNY | 56.99% |
| 2008 FY | 4.38 Million CNY | -68.21% |
| 2008 Q1 | 2.94 Million CNY | 49.93% |
| 2008 Q2 | 3.99 Million CNY | 35.73% |
| 2008 Q4 | -8.83 Million CNY | -240.77% |
| 2007 Q1 | 372.88 Thousand CNY | 187.76% |
| 2007 Q4 | 1.96 Million CNY | 299.29% |
| 2007 Q3 | -985.85 Thousand CNY | -107.93% |
| 2007 Q2 | 12.43 Million CNY | 3235.79% |
| 2007 FY | 13.79 Million CNY | 377.0% |
| 2006 Q2 | 3.83 Million CNY | 983.38% |
| 2006 Q3 | -868.61 Thousand CNY | -122.67% |
| 2006 Q4 | -424.9 Thousand CNY | 51.08% |
| 2006 FY | 2.89 Million CNY | -62.84% |
| 2006 Q1 | 353.61 Thousand CNY | 134.08% |
| 2005 Q4 | -1.03 Million CNY | -149.53% |
| 2005 Q1 | 1.58 Million CNY | 4.76% |
| 2005 Q2 | 5.13 Million CNY | 224.62% |
| 2005 Q3 | 2.09 Million CNY | -59.24% |
| 2005 FY | 7.78 Million CNY | -48.46% |
| 2004 FY | 15.09 Million CNY | 153.84% |
| 2004 Q1 | -8.31 Million CNY | -10.13% |
| 2004 Q2 | 14.24 Million CNY | 271.27% |
| 2004 Q3 | 7.65 Million CNY | -46.22% |
| 2004 Q4 | 1.51 Million CNY | -80.27% |
| 2003 Q2 | -4.86 Million CNY | 5.37% |
| 2003 Q4 | -7.55 Million CNY | 28.01% |
| 2003 Q1 | -5.13 Million CNY | 93.29% |
| 2003 Q3 | -10.48 Million CNY | -115.72% |
| 2003 FY | -28.03 Million CNY | 72.76% |
| 2002 Q3 | -9.33 Million CNY | -0.67% |
| 2002 FY | -102.91 Million CNY | -135.64% |
| 2002 Q1 | -7.76 Million CNY | 0.0% |
| 2002 Q2 | -9.27 Million CNY | -19.39% |
| 2002 Q4 | -76.54 Million CNY | -720.04% |
| 2001 FY | -43.67 Million CNY | -751.4% |
| 2000 FY | 6.7 Million CNY | 4.06% |
| 1999 FY | 6.44 Million CNY | 65.69% |
| 1998 FY | 3.88 Million CNY | -59.65% |
| 1997 FY | 9.63 Million CNY | -30.64% |
| 1996 FY | 13.89 Million CNY | -36.78% |
| 1995 FY | 21.97 Million CNY | -25.58% |
| 1994 FY | 29.52 Million CNY | -16.3% |
| 1993 FY | 35.28 Million CNY | 67.64% |
| 1992 FY | 21.04 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 4.3 Billion CNY | 98.675% |
| Zhangzhou Pientzehuang Pharmaceutical., Ltd | 2.79 Billion CNY | 97.962% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 591.57 Million CNY | 90.365% |
| Aurora Optoelectronics Co.,Ltd. | -675.27 Million CNY | 108.441% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | -38.27 Million CNY | 248.923% |
| NanJing Pharmaceutical Company Limited | 577.82 Million CNY | 90.135% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 90.07 Million CNY | 36.721% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.16 Billion CNY | 95.119% |